Shield Therapeutics shares rise as US sales boost interim revenue
(Alliance News) - Shield Therapeutics PLC on Thursday reported a narrowing of its half-year loss, bolstered by US sales and milestone payments globally, as it backed its full-year cash flow guidance. Read More